Insulin Delivery Devices Market was valued at USD 22.45 Bn. in 2023 and is expected to reach USD 38.55 Bn. at a CAGR of 8.03% during the forecast period 2024-3030.Insulin Delivery Devices Market Overview
Insulin Delivery Devices are medical devices approved by the FDA to assist in delivering insulin to individuals with type 1 and 2 diabetes. These devices offer various methods of insulin delivery, such as subcutaneous, transdermal, and others. The increasing worldwide incidence of diabetes and the growing awareness of insulin delivery devices among patients are key factors contributing to the rising market demand for these devices. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report
Insulin Delivery Devices Market Dynamics
Globally, an escalating prevalence of diabetes is the prominent reason behind Insulin Delivery Devices Market expansion. Owing to inappropriate eating habits and lack of physical work; diabetes incidences are rising at alarming rates in developing countries too. From the consumer’s side, usage complication and probability of injury due to injections have been resulting in a shift from invasive devices to minimally invasive ones. More and more minimally invasive devices are gaining demand around the globe, especially in developed nations. The insulin delivery devices market faces some peculiar challenges which have been and will continue to be hindering growth during the forecast period. Factors such as the prohibitive cost of insulin and insulin delivery devices, inconsistencies in adherence of insulin uptake and psychological resistances to self-injection due to needle-phobia are a major roadblock in Insulin Delivery Devices Market growth. Insulin Delivery Devices Market had the highest market in 2023. The need for better diabetes management will drive demand for the insulin pumps during the forecast period. Minimally invasive nature of pumps will increasingly attract more consumers over the coming years, especially in an industrialized nation; however, their cost will prove to be a major restraining factor for the business growth. Increasing demand for insulin-delivering devices and minimally invasive alternatives such as pumps, advancements in insulin devices in terms of design and functioning, an increasing prevalence of diabetes and ease offered by some insulin delivery devices to patients are some of the major market growth driving factors observed worldwide.Insulin Delivery Devices Market Segment Analysis
Based on Product Type, the Insulin Pens Segment has been dominant in the global Insulin delivery devices market in 2023. The widespread use, precision, and patient-friendly features of insulin pens have led to their dominance in diabetes management. Both disposable and reusable insulin pens are preferred for their ease of use, portability, and ability to provide accurate dosing, improving patient adherence to insulin therapy. Major players in this market, such as Novo Nordisk, Sanofi, and Boehringer Ingelheim, offer innovative products like NovoPen 6 and SoloSTAR known for their user-friendly features and advanced technology. For instance, Novo Nordisk’s NovoPen Echo includes a memory function to track doses, improving patient compliance. The growing prevalence of diabetes and the increasing preference for convenient and reliable insulin delivery methods have fueled the segment's growth. Additionally, ongoing advances in pen design, such as the integration of smart technology for digital tracking and personalized insulin delivery, are expected to strengthen the segment's dominance in the market. The robust growth of the insulin pens segment reflects its vital role in enhancing the quality of life for diabetes patients and addressing the evolving needs of modern diabetes care.Insulin Delivery Devices Market Regional Analysis
In 2023, North America dominated the insulin delivery devices market with a significant share of about 40-45%. The dominance is due to the high prevalence of diabetes, advanced healthcare infrastructure, and substantial investments in diabetes management technologies in the region. The United States stands out as a major contributor, given its well-established healthcare system and a considerable market for innovative insulin delivery devices. Key players in the North American market, such as Medtronic, Tandem Diabetes Care, and Insulet Corporation, offer cutting-edge products like the MiniMed 780G insulin pump, t:slim X2 insulin pump, and Omnipod 5, respectively. These devices are leading the way in diabetes management by offering advanced features such as automated insulin delivery and integration with continuous glucose monitoring systems. Canada also has a significant role in this market, with an increasing adoption of advanced insulin delivery technologies and a growing focus on improving diabetes care. Additionally, the region's rising awareness of diabetes management and the shift toward personalized medicine are expected to maintain North America's dominant position in the global insulin delivery devices market. The objective of the report is to present comprehensive Global Insulin Delivery Devices Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Insulin Delivery Devices Market North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Global Insulin Delivery Devices Market North America for Asia Pacific size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Insulin Delivery Devices Market North America for Asia Pacific make the report investor’s guide.Insulin Delivery Device Industry Ecosystem
Insulin Delivery Devices Market Scope :Inquire before buying
Global Insulin Delivery Devices Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 22.45 Bn Forecast Period 2024 to 2030 CAGR: 8.03% Market Size in 2030: USD 38.55 Bn Segments Covered: by Product Type Insulin Pens Insulin Syringes Insulin Pumps Others by Distribution Channel Hospital Pharmacies Retail Pharmacies Online Sales Diabetes Clinics/Centres Insulin Delivery Devices Market By Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Insulin Delivery Devices Market Key Players:
1. Eli Lilly 2. Sanofi 3. Novo Nordisk 4. Beckton and Dickenson 5. Roche 6. Medtronic 7. Insulet Corporation 8. Ypsomed 9. Tandem Diabetes Care, Inc. 10. Animas Corporation 11. B. Braun Melsungen AG 12. Johnson & Johnson 13. Medtrum Technologies 14. Cellnova 15. Roche Holdings 16. Spring Health Solutions 17. Debiotech 18. CeQur 19. Valeritas Holding 20. Abbott Diabetes CareFrequently Asked Questions:
1. Which region has the largest Global market share? Ans: In 2023, North America has the largest market share in the global market. 2. What is the growth rate of the Global market? Ans: The Global market is growing at a CAGR of 9.1% during the forecasting period 2024-2030. 3. What is the scope of the Global market report? Ans: The Global market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in the Global market? Ans: The important key players in the Global market are – Eli Lilly, Sanofi, Novo Nordisk, Beckton and Dickenson, Roche, Medtronic, Insulet Corporation, Ypsomed, Tandem Diabetes Care, Inc., Animas Corporation, B. Braun Melsungen AG, Johnson & Johnson, Medtrum Technologies, Cellnova, Roche Holdings, Spring Health Solutions, Debiotech, CeQur, Valeritas Holding, and Abbott Diabetes Care 5. What is the forecast period of the global market? Ans: The Global market is studied from 2023 to 2030.
1. Insulin Delivery Devices Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Insulin Delivery Devices Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Company Location 2.5.3. Product Segment 2.5.4. End-user Segment 2.5.5. Revenue (2023) 2.5.6. Growth Rate (Y-O-Y in %) 2.5.7. Key Development 2.5.8. Market Share 2.6. Industry Ecosystem Analysis 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Consolidation of the Market 2.8.1. Strategic Initiatives and Developments 2.8.2. Mergers and Acquisitions 2.8.3. Collaborations and Partnerships 2.8.4. Product Launches and Innovations 3. Insulin Delivery Devices Market: Dynamics 3.1. Insulin Delivery Devices Market Trends 3.2. Insulin Delivery Devices Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. PESTLE Analysis 3.5. Industry Insights 3.5.1. Growing Demand For Hybrid Closed-Loop Systems/Artificial Pancreas Device Systems 3.5.2. Synchronization Of Smart Insulin Pens With CGM Systems To Promote Diabetes Data Sharing 3.5.3. Major Smart Insulin Pens Available Globally 3.6. Value Chain Analysis 3.7. Technology Roadmap 3.8. Regulatory Landscape 3.8.1. Regulatory Bodies, Government Agencies, and Other Organizations 3.8.2. Regulatory Framework by Region 3.9. Patent Analysis 3.9.1. Jurisdiction and Top Applicant Analysis 4. Insulin Delivery Devices Market: Global Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 4.1. Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 4.1.1. Insulin Pens 4.1.2. Insulin Syringes 4.1.3. Insulin Pumps 4.1.4. Others 4.2. Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 4.2.1. Hospital Pharmacies 4.2.2. Retail Pharmacies 4.2.3. Online Sales 4.2.4. Diabetes Clinics/Centres 4.3. Insulin Delivery Devices Market Size and Forecast, by Region (2023-2030) 4.3.1. North America 4.3.2. Europe 4.3.3. Asia Pacific 4.3.4. Middle East and Africa 4.3.5. South America 5. North America Insulin Delivery Devices Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 5.1. North America Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 5.1.1. Insulin Pens 5.1.2. Insulin Syringes 5.1.3. Insulin Pumps 5.1.4. Others 5.2. North America Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 5.2.1. Hospital Pharmacies 5.2.2. Retail Pharmacies 5.2.3. Online Sales 5.2.4. Diabetes Clinics/Centres 5.3. North America Insulin Delivery Devices Market Size and Forecast, by Country (2023-2030) 5.3.1. United States 5.3.1.1. United States Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 5.3.1.1.1. Insulin Pens 5.3.1.1.2. Insulin Syringes 5.3.1.1.3. Insulin Pumps 5.3.1.1.4. Others 5.3.1.2. United States Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 5.3.1.2.1. Hospital Pharmacies 5.3.1.2.2. Retail Pharmacies 5.3.1.2.3. Online Sales 5.3.1.2.4. Diabetes Clinics/Centres 5.3.2. Canada 5.3.2.1. Canada Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 5.3.2.1.1. Insulin Pens 5.3.2.1.2. Insulin Syringes 5.3.2.1.3. Insulin Pumps 5.3.2.1.4. Others 5.3.2.2. Canada Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 5.3.2.2.1. Hospital Pharmacies 5.3.2.2.2. Retail Pharmacies 5.3.2.2.3. Online Sales 5.3.2.2.4. Diabetes Clinics/Centres 5.3.3. Mexico 5.3.3.1. Mexico Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 5.3.3.1.1. Insulin Pens 5.3.3.1.2. Insulin Syringes 5.3.3.1.3. Insulin Pumps 5.3.3.1.4. Others 5.3.3.2. Mexico Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 5.3.3.2.1. Hospital Pharmacies 5.3.3.2.2. Retail Pharmacies 5.3.3.2.3. Online Sales 5.3.3.2.4. Diabetes Clinics/Centres 6. Europe Insulin Delivery Devices Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 6.1. Europe Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.2. Europe Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 6.3. Europe Insulin Delivery Devices Market Size and Forecast, by Country (2023-2030) 6.3.1. United Kingdom 6.3.1.1. United Kingdom Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.3.1.2. United Kingdom Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 6.3.2. France 6.3.2.1. France Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.3.2.2. France Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 6.3.3. Germany 6.3.3.1. Germany Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.3.3.2. Germany Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 6.3.4. Italy 6.3.4.1. Italy Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.3.4.2. Italy Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 6.3.5. Spain 6.3.5.1. Spain Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.3.5.2. Spain Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 6.3.6. Sweden 6.3.6.1. Sweden Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.3.6.2. Sweden Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 6.3.7. Austria 6.3.7.1. Austria Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.3.7.2. Austria Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 6.3.8. Rest of Europe 6.3.8.1. Rest of Europe Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 6.3.8.2. Rest of Europe Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 7. Asia Pacific Insulin Delivery Devices Market Size and Forecast by Segmentation (by Value in USD Billion ) (2023-2030) 7.1. Asia Pacific Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 7.2. Asia Pacific Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 7.3. Asia Pacific Insulin Delivery Devices Market Size and Forecast, by Country (2023-2030) 7.3.1. China 7.3.1.1. China Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 7.3.1.2. China Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 7.3.2. S Korea 7.3.2.1. S Korea Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 7.3.2.2. S Korea Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 7.3.3. Japan 7.3.3.1. Japan Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 7.3.3.2. Japan Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 7.3.4. India 7.3.4.1. India Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 7.3.4.2. India Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 7.3.4.3. India Insulin Delivery Devices Market Size and Forecast, by End-User (2023-2030) 7.3.5. Australia 7.3.5.1. Australia Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 7.3.5.2. Australia Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 7.3.6. ASEAN 7.3.6.1. ASEAN Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 7.3.6.2. ASEAN Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 7.3.7. Rest of Asia Pacific 7.3.7.1. Rest of Asia Pacific Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 7.3.7.2. Rest of Asia Pacific Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 8. Middle East and Africa Insulin Delivery Devices Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030) 8.1. Middle East and Africa Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 8.2. Middle East and Africa Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 8.3. Middle East and Africa Insulin Delivery Devices Market Size and Forecast, by Country (2023-2030) 8.3.1. South Africa 8.3.1.1. South Africa Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 8.3.1.2. South Africa Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 8.3.2. GCC 8.3.2.1. GCC Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 8.3.2.2. GCC Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 8.3.3. Rest of ME&A 8.3.3.1. Rest of ME&A Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 8.3.3.2. Rest of ME&A Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 9. South America Insulin Delivery Devices Market Size and Forecast by Segmentation (by Value in USD Billion) (2023-2030 9.1. South America Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 9.2. South America Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 9.3. South America Insulin Delivery Devices Market Size and Forecast, by Country (2023-2030) 9.3.1. Brazil 9.3.1.1. Brazil Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 9.3.1.2. Brazil Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 9.3.2. Argentina 9.3.2.1. Argentina Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 9.3.2.2. Argentina Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 9.3.3. Rest Of South America 9.3.3.1. Rest Of South America Insulin Delivery Devices Market Size and Forecast, by Product Type (2023-2030) 9.3.3.2. Rest Of South America Insulin Delivery Devices Market Size and Forecast, by Distribution Channel (2023-2030) 10. Company Profile: Key Players 10.1. Eli Lilly 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Sanofi 10.3. Novo Nordisk 10.4. Beckton and Dickenson 10.5. Roche 10.6. Medtronic 10.7. Insulet Corporation 10.8. Ypsomed 10.9. Tandem Diabetes Care, Inc. 10.10. Animas Corporation 10.11. B. Braun Melsungen AG 10.12. Johnson & Johnson 10.13. Medtrum Technologies 10.14. Cellnova 10.15. Roche Holdings 10.16. Spring Health Solutions 10.17. Debiotech 10.18. CeQur 10.19. Valeritas Holding 10.20. Abbott Diabetes Care 11. Key Findings & Analyst Recommendations 12. Global Insulin Delivery Devices Market: Research Methodology 12.1. Top Down Approach 12.2. Bottom-Up Approach
